Literature DB >> 11062530

Malaria vaccines-targeting infected hepatocytes.

S L Hoffman1, D L Doolan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11062530     DOI： 10.1038/81315

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  19 in total

1.  Identification of non-CSP antigens bearing CD8 epitopes in mice immunized with irradiated sporozoites.

Authors:  Satish Mishra; Urvashi Rai; Takayuki Shiratsuchi; Xiangming Li; Yannick Vanloubbeeck; Joe Cohen; Ruth S Nussenzweig; Elizabeth A Winzeler; Moriya Tsuji; Victor Nussenzweig
Journal:  Vaccine       Date:  2011-07-30       Impact factor: 3.641

2.  A Sporozoite- and Liver Stage-expressed Tryptophan-rich Protein Plays an Auxiliary Role in Plasmodium Liver Stage Development and Is a Potential Vaccine Candidate.

Authors:  Dabbu Kumar Jaijyan; Himanshu Singh; Agam Prasad Singh
Journal:  J Biol Chem       Date:  2015-05-10       Impact factor: 5.157

Review 3.  Genetic vaccination approaches against malaria based on the circumsporozoite protein.

Authors:  Sandra Scheiblhofer; Richard Weiss; Josef Thalhamer
Journal:  Wien Klin Wochenschr       Date:  2006       Impact factor: 1.704

4.  Plasmodium liver stage developmental arrest by depletion of a protein at the parasite-host interface.

Authors:  Ann-Kristin Mueller; Nelly Camargo; Karine Kaiser; Cathy Andorfer; Ute Frevert; Kai Matuschewski; Stefan H I Kappe
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-07       Impact factor: 11.205

5.  Mice deficient in interleukin-4 (IL-4) or IL-4 receptor alpha have higher resistance to sporozoite infection with Plasmodium berghei (ANKA) than do naive wild-type mice.

Authors:  Michael Saeftel; Andreas Krueger; Sandra Arriens; Volker Heussler; Paul Racz; Bernhard Fleischer; Frank Brombacher; Achim Hoerauf
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

6.  Gamma interferon responses to Plasmodium falciparum liver-stage antigen 1 and thrombospondin-related adhesive protein and their relationship to age, transmission intensity, and protection against malaria.

Authors:  Chandy C John; Ann M Moormann; Peter O Sumba; Ayub V Ofulla; Daniel C Pregibon; James W Kazura
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

7.  Class II-restricted protective immunity induced by malaria sporozoites.

Authors:  Giane A Oliveira; Kota Arun Kumar; J Mauricio Calvo-Calle; Caroline Othoro; David Altszuler; Victor Nussenzweig; Elizabeth H Nardin
Journal:  Infect Immun       Date:  2007-12-26       Impact factor: 3.441

8.  Transcriptionally active PCR for antigen identification and vaccine development: in vitro genome-wide screening and in vivo immunogenicity.

Authors:  David P Regis; Carlota Dobaño; Paola Quiñones-Olson; Xiaowu Liang; Norma L Graber; Maureen E Stefaniak; Joseph J Campo; Daniel J Carucci; David A Roth; Huaping He; Philip L Felgner; Denise L Doolan
Journal:  Mol Biochem Parasitol       Date:  2007-11-22       Impact factor: 1.759

9.  A combined transcriptome and proteome survey of malaria parasite liver stages.

Authors:  Alice S Tarun; Xinxia Peng; Ronald F Dumpit; Yuko Ogata; Hilda Silva-Rivera; Nelly Camargo; Thomas M Daly; Lawrence W Bergman; Stefan H I Kappe
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-02       Impact factor: 11.205

10.  CD8+ T cells specific for a malaria cytoplasmic antigen form clusters around infected hepatocytes and are protective at the liver stage of infection.

Authors:  Kazumi Kimura; Daisuke Kimura; Yoshifumi Matsushima; Mana Miyakoda; Kiri Honma; Masao Yuda; Katsuyuki Yui
Journal:  Infect Immun       Date:  2013-07-29       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.